Will Scorpio X-Series exceed 15% of ALAB's total revenue by Q4 2026?
Current Prediction
Why This Question Matters
Scorpio X is the linchpin of the scale-up switching thesis. Management expects it to become the largest product line and claims $20B TAM by 2030. If Scorpio X exceeds 15% of revenue by Q4 2026, it validates the revenue diversification narrative and supports the premium valuation. If it falls short, the $25B SAM claim remains aspirational and the narrative-reality gap widens.
Prediction Distribution
Individual Predictions(9 runs)
Scorpio X shipped only 'preproduction quantities' in Q4 2025 — this language suggests very early stage, potentially engineering samples rather than production volumes. Management expects 'material ramp' in H2 2026, but reaching 15% of total revenue by Q4 2026 requires rapid acceleration. If Q4 2026 revenue is ~$350-400M (reasonable at continued growth), 15% means ~$52-60M from Scorpio X alone. Going from preproduction to $50M+ in quarterly revenue within 9 months is aggressive for a new system product. Scorpio P took multiple quarters to reach 15%. UALink adoption timeline and cluster deployment cycles add further uncertainty.
The Myth Meter's finding about the gap between narrative and resource allocation is relevant here. Only 3 of 135 job postings are in optical, suggesting scale-up investment is still early. Scorpio X is a system-level product for scale-up AI clusters, which requires hyperscaler qualification and deployment cycles. Even if hyperscalers are designing clusters with Scorpio X, the deployment timelines typically lag product availability by 6-12 months. The 15% threshold by Q4 2026 assumes a faster ramp than historical semiconductor product cycles suggest. UALink revenue is expected in 2027, adding to timing risk.
Scorpio P's trajectory provides a useful analog. It exceeded the 10% target and reached >15% within its first full year of production ramp. If Scorpio X follows a similar trajectory from its H2 2026 material ramp, 15% by Q4 2026 is possible but requires the ramp to accelerate faster than Scorpio P did. The 10+ customer platforms mentioned for Scorpio and the NVLink Fusion opportunity provide multiple demand vectors. However, 'material ramp expected H2 2026' means Q3-Q4 revenue is front-loaded to Q4, making it harder to reach 15% for the full quarter. The question specifically asks about Q4 2026, which is the best possible quarter for this metric.
Scorpio X is in preproduction as of Q4 2025. Material ramp is expected H2 2026, meaning production volumes start appearing in Q3-Q4 2026. Reaching 15% of Q4 revenue requires a very steep ramp curve in just 2-3 quarters. Semiconductor product ramps rarely go from preproduction to 15% of total company revenue in under 4 quarters. The hyperscaler qualification and deployment cycle adds latency. While management is optimistic, the timeline is too compressed for 15% in Q4 2026.
The question hinges on deployment timing. Even if Scorpio X is being designed into hyperscaler clusters now, production deployments at scale require fabrication ramp, system integration, customer qualification, and rack deployment. Each step takes weeks to months. With preproduction in Q4 2025 and material ramp expected H2 2026, Q4 2026 might see 5-10% contribution rather than 15%. Management might report combined Scorpio (P+X) data rather than X-specific, complicating resolution. The 15% threshold is specific and demanding.
The NVLink Fusion partnership with NVIDIA could accelerate Scorpio X adoption by providing a pull-through from NVIDIA's ecosystem. However, this is a recently announced partnership and the business model is still unclear (CEO deferred financial details). Even with NVIDIA pull-through, the physical deployment timeline for hyperscaler-scale AI clusters is 6-12 months from design finalization. Starting from preproduction in Q4 2025, 15% by Q4 2026 requires near-perfect execution across an uncertain supply chain.
Preproduction quantities in Q4 2025 → material ramp H2 2026 → 15% by Q4 2026 is a compressed timeline. Scorpio P took multiple quarters from ramp to 15%. While Scorpio X may benefit from existing Scorpio platform relationships, the scale-up switching market is newer and qualification cycles may be longer. More likely 8-12% by Q4 2026.
The 15% threshold is high for a product in preproduction. The resolution criteria require management disclosure or analyst confirmation, which may not happen even if the product is ramping well. Management has been cagey about product-level revenue breakdowns. The combination of product ramp uncertainty and disclosure uncertainty pushes the probability lower.
If 10+ customer platforms are designing with Scorpio and the AI cluster deployment cycle accelerates, 15% is possible but not probable by Q4 2026. The base case is that Scorpio X contributes meaningfully (5-12%) but doesn't reach the 15% threshold until Q1-Q2 2027.
Resolution Criteria
Resolves YES if management discloses in Q4 2026 earnings call or filing that Scorpio X-Series revenue exceeds 15% of total quarterly revenue, or if analyst models confirm this threshold based on disclosed data.
Resolution Source
ALAB Q4 CY2026 earnings call or 10-K filing
Source Trigger
Scorpio X revenue contribution needs to reach meaningful revenue (>15% of total) by Q3-Q4 2026 to validate the switching TAM thesis
Full multi-lens equity analysis